Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming. - Park, Su Jung; Cerella, Claudia; Kang, Jin Mo; Byun, Jinyoung; Kum, David; Orlikova-Boyer, Barbora; Lorant, Anne; Schnekenburger, Michael; Al-Mourabit, Ali; Christov, Christo; Lee, Juyong; Han, Byung Woo; et al. (Journal of Experimental & Clinical Cancer Research (17569966), 2025)